{"filings":[{"id":99264,"accession_number":"0001193125-26-214569","cik":862692,"company_name":"CRYO CELL INTERNATIONAL INC","ticker":"CCEL","form_type":"8-K","filed_at":"2026-05-08T23:59:59+00:00","items":["3.01","7.01","9.01"],"status":"ready","headline":"NYSE American accepts Cryo-Cell compliance plan; trading continues through Sep 2027","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received notice of non-compliance on Mar 12, 2026 for stockholders' deficit and net losses in two of three fiscal years ending Nov 30, 2025.","Compliance plan accepted May 6, 2026; plan period extends to September 9, 2027 to regain listing standards.","Common stock remains listed and traded on NYSE American during plan period, subject to periodic review.","Failure to regain compliance or make progress by deadline could result in delisting proceedings.","Company reported stockholders' deficit as of Nov 30, 2025 and net losses in FY2023, FY2024, FY2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":27306959.497058824,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115149,"accession_number":"0001193125-26-104392","cik":862692,"company_name":"CRYO CELL INTERNATIONAL INC","ticker":"CCEL","form_type":"8-K","filed_at":"2026-03-12T23:59:59+00:00","items":["3.01","7.01","9.01"],"status":"ready","headline":"Cryo-Cell receives NYSE American delisting notice over stockholders' deficit and net losses","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["NYSE American cited stockholders' deficit as of Nov 30, 2025 and net losses in two of three fiscal years ended Nov 30, 2025.","Company must submit compliance plan by April 8, 2026; if accepted, extension up to 18 months possible.","Trading of CCEL common stock continues on NYSE American while company pursues compliance plan.","No assurance that plan will be accepted or that compliance can be regained; delisting possible if not."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":27306959.497058824,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131556,"accession_number":"0001193125-25-277872","cik":862692,"company_name":"CRYO CELL INTERNATIONAL INC","ticker":"CCEL","form_type":"8-K","filed_at":"2025-11-12T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Cryo-Cell International suspends Q4 2025 dividend; future payouts uncertain","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Company will not declare a quarterly cash dividend for Q4 fiscal 2025.","Decision driven by financial performance, capital requirements, and strategic priorities.","No commitment to future dividends; each quarter's decision will be evaluated separately.","Announced on November 12, 2025 via Form 8-K."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":27306959.497058824,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131555,"accession_number":"0001193125-25-248883","cik":862692,"company_name":"CRYO CELL INTERNATIONAL INC","ticker":"CCEL","form_type":"8-K","filed_at":"2025-10-23T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Cryo-Cell International amends credit agreement; reduces revolver to $8M, extends maturities to 2027/2032","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Fifth Amendment extends RCF maturity to Oct 2027 and Term Loan maturity to Jul 2032.","Revolving credit commitment reduced from $10M to $8M; subsidiary Celle Corp. added as guarantor.","Applicable margins revised: Base Rate +4.25% (Term), +3.75% (Revolver); SOFR +3.25% (Term), +2.75% (Revolver); commitment fee 0.25%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":27306959.497058824,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148130,"accession_number":"0001193125-25-200170","cik":862692,"company_name":"CRYO CELL INTERNATIONAL INC","ticker":"CCEL","form_type":"8-K","filed_at":"2025-09-10T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Cryo-Cell sets 2025 annual meeting for Oct 21; record date Sept 15","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Annual Meeting scheduled for October 21, 2025.","Record date for voting is September 15, 2025.","Stockholder proposals and director nominations must be submitted by September 20, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":27306959.497058824,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166890,"accession_number":"0000950170-25-076433","cik":862692,"company_name":"CRYO CELL INTERNATIONAL INC","ticker":"CCEL","form_type":"8-K","filed_at":"2025-05-22T23:59:59+00:00","items":["1.02"],"status":"ready","headline":"Duke terminates patent license with Cryo-Cell effective May 17; Cryo-Cell previously sought arbitration","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Duke University terminated Patent and Technology License Agreement effective May 17, 2025, claiming Cryo-Cell breached.","Cryo-Cell had previously filed a demand for arbitration against Duke, alleging fraudulent inducement and breach.","The license granted Cryo-Cell exclusive rights to commercialize certain products and processes for human disease treatment.","Termination could impact Cryo-Cell's ability to commercialize the licensed technology; arbitration is ongoing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":27306959.497058824,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166889,"accession_number":"0000950170-25-067147","cik":862692,"company_name":"CRYO CELL INTERNATIONAL INC","ticker":"CCEL","form_type":"8-K","filed_at":"2025-05-08T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Cryo-Cell reduces quarterly dividend to $0.15 per share, payable May 30, 2025","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Board declares reduced quarterly cash dividend of $0.15 per share, citing current economic environment and capital allocation alternatives.","Dividend payable May 30, 2025 to shareholders of record as of May 21, 2025.","Board may change dividend policy at any time; no assurance of future dividends."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":27306959.497058824,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200887,"accession_number":"0000950170-24-119642","cik":862692,"company_name":"CRYO CELL INTERNATIONAL INC","ticker":"CCEL","form_type":"8-K","filed_at":"2024-10-31T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Cryo-Cell International reports annual meeting vote results; all director nominees elected","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Directors David Portnoy, Harold Berger, Mark Portnoy, and Daniel Mizrahi each elected with For votes ranging from 3.6M to 4.1M.","Ratification of WIPFLI LLC as independent auditor passed: 6,697,620 For vs 186 Against.","Non-binding advisory resolution on executive compensation approved: 4,152,942 For, 287,390 Against.","Authorization to vote on other business passed with 3,571,034 For, 855,538 Against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":27306959.497058824,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200886,"accession_number":"0000950170-24-118607","cik":862692,"company_name":"CRYO CELL INTERNATIONAL INC","ticker":"CCEL","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Cryo-Cell initiates $0.25 quarterly cash dividend, payable Nov 29, 2024","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Quarterly dividend of $0.25 per share declared for common stock.","Record date: November 15, 2024; payment date: November 29, 2024.","Chairman David Portnoy says dividend does not detract from ongoing strategic alternatives review.","Board will evaluate policy regularly and may increase, decrease, or suspend dividends based on earnings and cash flows."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":27306959.497058824,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200885,"accession_number":"0000950170-24-115106","cik":862692,"company_name":"CRYO CELL INTERNATIONAL INC","ticker":"CCEL","form_type":"8-K","filed_at":"2024-10-17T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cryo-Cell Q3 revenue $8.07M, net income $1.05M; strategic review ongoing, spinoff on hold","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $8.07M vs $7.87M YoY; net income $1.05M ($0.13/diluted) vs $0.68M ($0.08).","Gains on marketable securities $522k vs $93k YoY, boosting earnings.","Company exploring strategic alternatives to maximize shareholder value; process ongoing.","Spinoff of Celle Corp on hold due to arbitration demand with Duke University (see Form 10-Q).","Board considering instituting regular quarterly dividend; no decision yet."],"consensus_eps_estimate":null,"consensus_eps_actual":0.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":23961761.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":27306959.497058824,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216880,"accession_number":"0000950170-24-107340","cik":862692,"company_name":"CRYO CELL INTERNATIONAL INC","ticker":"CCEL","form_type":"8-K","filed_at":"2024-09-17T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Cryo-Cell sets 2024 annual meeting for Oct 29; record date Sep 20","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Annual Meeting of Stockholders scheduled for October 29, 2024.","Record date for voting eligibility fixed as September 20, 2024.","Stockholder proposals or director nominations due within 10 days of Sep 17 public disclosure."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":27306959.497058824,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}